The European Union is reportedly in talks to make advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna (MRNA), Sanofi (SNY) and …
Johnson & Johnson (JNJ) exceeded analysts’ profit and sales expectations in the second quarter and lifted its earnings guidance for the full year …
Johnson & Johnson’s (JNJ) bid to toss out a jury verdict in favor of women who blamed their ovarian cancer on its baby …
The European Commission is reportedly in advanced talks with Johnson & Johnson (JNJ) to purchase up-front doses of its COVID-19 vaccine candidate. According …
Johnson & Johnson (JNJ) said on Wednesday that it will start human trials of its COVID-19 vaccine as early as in the second …
Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York …
Johnson & Johnson (JNJ) has decided to permanently discontinue talc-based Johnson’s Baby Powder in both the US and Canada, citing declining demand and …
Johnson & Jonhson’s (JNJ) Janssen Pharmaceutical has submitted a filing for Japanese approval of a new subcutaneous formulation of daratumumab, an intravenous (IV) treatment …
Johnson & Johnson (JNJ) today announced earning results for first-quarter 2020. The company revealed Q1 Non-GAAP EPS of $2.
Almost three months have passed since COVID-19 began its spread beyond China’s borders, and the market remains in free fall. Capping off another volatile week, stocks fell on Friday April 3 in response …
